Trial Profile
A Phase I/II study of NK012 in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs NK 012 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Nippon Kayaku
- 07 Oct 2015 New trial record